Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
AirSculpt Technologies
AIRS
$339M
| $33.6K | ﹤0.01% |
14,393
-6,598
| -31% | -$29.6K |
|
4552
Black Stone Minerals
BSM
$3.18B
| $33.3K | ﹤0.01% |
2,183
-35,212
| -94% | -$529K |
|
4553
Seer Inc
SEER
$122M
| $33.2K | ﹤0.01% |
19,673
-30,751
| -61% | -$66.9K |
|
4554
Value Line
VALU
$321M
| $33.1K | ﹤0.01% |
855
-398
| -32% | -$16.4K |
|
4555
PMV Pharmaceuticals
PMVP
$59.2M
| $32.9K | ﹤0.01% |
30,197
| – | – |
|
4556
Assembly Biosciences
ASMB
$498M
| $32.8K | ﹤0.01% |
3,431
+437
| +15% | +$5.71K |
|
4557
Crexendo
CXDO
$223M
| $32.8K | ﹤0.01% |
6,732
-18,956
| -74% | -$111K |
|
4558
NextCure
NXTC
$16.8M
| $32.4K | ﹤0.01% |
5,627
| – | – |
|
|
SVCO
4559
Silvaco Group
SVCO
$261M
| $32K | ﹤0.01% |
7,020
-2,495
| -26% | -$17.1K |
|
4560
Vanguard High Dividend Yield ETF
VYM
$80.9B
| $32K | ﹤0.01% |
248
| – | – |
|
|
MESO
4561
Mesoblast
MESO
$1.84B
| $31.9K | ﹤0.01% |
2,557
+657
| +35% | +$10.8K |
|
4562
Fortis
FTS
$29B
| $31.9K | ﹤0.01% |
699
-6,843
| -91% | -$298K |
|
4563
Skye Bioscience
SKYE
$20M
| $31.8K | ﹤0.01% |
20,006
-49,614
| -71% | -$135K |
|
4564
Bain Capital Specialty
BCSF
$806M
| $31.5K | ﹤0.01% |
+1,900
| New | +$33.5K |
|
4565
LanzaTech
LNZA
$61.2M
| $31.5K | ﹤0.01% |
1,302
-474
| -27% | -$42.7K |
|
|
ASBPW
4566
Aspire Biopharma Warrant
ASBPW
| $31.4K | ﹤0.01% |
350,000
| – | – |
|
4567
USA Compression Partners
USAC
$3.79B
| $31.4K | ﹤0.01% |
1,163
+582
| +100% | +$15.4K |
|
4568
Invesco KBW Bank ETF
KBWB
$6.84B
| $31.1K | ﹤0.01% |
496
-2,037
| -80% | -$137K |
|
4569
PepGen
PEPG
$122M
| $31K | ﹤0.01% |
22,043
-4,370
| -17% | -$9K |
|
|
CHN
4570
DELISTED
China Fund
CHN
| $30.9K | ﹤0.01% |
+2,409
| New | +$30.1K |
|
4571
Silicom
SILC
$229M
| $30.8K | ﹤0.01% |
2,068
+1,068
| +107% | +$17.4K |
|
4572
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
| $30.5K | ﹤0.01% |
+330
| New | +$30.4K |
|
4573
Drilling Tools International
DTI
$82.6M
| $30.4K | ﹤0.01% |
12,810
-5,414
| -30% | -$16.7K |
|
4574
CAMP4 Therapeutics
CAMP
$179M
| $30K | ﹤0.01% |
7,508
-3,162
| -30% | -$15.3K |
|
4575
YieldMax MSTR Option Income Strategy ETF
MSTY
$715M
| $30K | ﹤0.01% |
295
| – | – |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.